1st Rare Disease Action Summit 2026

RARE DISEASES Action SUMMIT.jpg
RARE DISEASES Action SUMMIT.jpg

RARE DISEASES Action SUMMIT

Rare diseases impact millions of patients and families across India, yet continue to remain underdiagnosed, under-prioritized, and under-resourced within the healthcare ecosystem. While policy frameworks like the National Policy for Rare Diseases (NPRD) have laid important foundations, the real challenge lies in translating policy intent into on-ground action, equitable access, and sustainable care models.

The Rare Disease Action Summit 2026, convened on Rare Disease Day – 11 March 2026, serves as a national platform to move the conversation from awareness to action. Bringing together policymakers, clinicians, patient advocacy groups, industry leaders, researchers, and global experts, the Summit aims to accelerate collaborative solutions that address diagnosis, treatment access, financing, and inclusion of rare diseases as a national health priority.

Anchored in the theme “Driving Action for Rare Diseases: Making Them a National Health Priority”, the Summit will focus on strengthening policy implementation, enabling public– private partnerships, advancing innovation, & ensuring patient-centric outcomes—especially for high-burden and underserved rare disease categories. Rare diseases impact millions of patients and families across India, yet continue to remain underdiagnosed, under-prioritized, and under-resourced within the healthcare ecosystem. While policy frameworks like the National Policy for Rare Diseases (NPRD) have laid important foundations, the real challenge lies in translating policy intent into on-ground action, equitable access, and sustainable care models.

Key Discussion Points

Key Objective

AGENDA 2026

SESSION 1 | OPENING PLENARY
Rare Disease Day 2026: A Collective Call for Action

To formally inaugurate the Summit and set a tone of urgency, empathy, & shared national responsibility

Inclusion, Implementation & Impact: Strengthening the National Policy for Rare Diseases (NPRD)

To examine policy frameworks and implementation challenges under the NPRD.

Where Giving Comes Full Circle: Creating Lifelines for Rare Lives

To bring together compassionate individuals & philanthropic leaders to explore how thoughtful giving can bridge critical gaps in diagnosis, treatment access, & long-term support for rare disease patients— ensuring no family faces their journey alone

Rare Diseases: Addressing Treatment Access & Long-Term Sustainability

To address the unique access and affordability challenges associated with Category 3 rare diseases

Living Rare: The Human Cost of Delayed Diagnosis & Limited Access

To highlight real-world patient and caregiver experiences and systemic gaps

Beyond Treatment: Building Sustainable Rare Disease Ecosystems

To identify collaborative models that improve access, affordability, and continuity of care

The Rare Disease Action Roadmap: Commitments Beyond 2026

To consolidate Summit deliberations into a clear, action-oriented roadmap

Speakers 2026

Hon'ble Minister of State for Social Justice and Empowerment

Government of India

Hon’ble Member of Parliament (Rajya Sabha) & Chairperson

Indian Medical Parliamentarians’ Forum, India.

Assistant Director General (ADG), Directorate General of Health Services

Ministry of Health & Family Welfare, Government of India.

Country Medical Director

Medical Affairs, AstraZeneca

Founder and CEO

Nucleome Informatics Pvt Ltd

Co-Founder & Director - Patient Advocacy

Cure SMA Foundation of India

Director

RS Associates

Scientist-E

Indian Council of Medical Research (ICMR), New Delhi, India.

Emeritus Scientist, Former Professor & Head – Department of Pediatrics (Division of Genetics)

Indian Council of Medical Research (ICMR), All India Institute of Medical Sciences (AIIMS)

Director Professor, Department of Paediatrics & Head,

Maulana Azad Medical College & Lok Nayak Hospital, New Delhi

Country Lead and Managing Director & General Manager, Pharma,

Sanofi India Limited, India.

Director of Pediatrics & Senior Consultant – Pediatric Nephrology

Indraprastha Apollo Hospitals, New Delhi, India.

Former Director & CEO – AIIMS Bhopal; Director Medical Research

Aarupadai Veedu Medical College (Vinayaka Mission’s Research Foundation), Pondicherry, India.

Professor – Pediatrics & In-Charge, Genetic Clinic and Pediatric Genetics Research Laboratory

Seth G.S. Medical College & KEM Hospital, Mumbai, India.

Associate Professor – Department of Pediatric Medicine

JK Lone Hospital, SMS Medical College, Jaipur, India

Director – Patient Academy for Innovation and Research (PAIR) & CEO

DakshamA Health and Education

Head – Diagnostics Division

Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, India.

Vice President – Genomics

Agilus Diagnostics Ltd. India.

Child Neurology Division & Coordinator – DM Paediatric Neurology Programme, Department of Pediatrics

All India Institute of Medical Sciences, New Delhi

Associate Secretary General

Indian Pharmaceutical Alliance (IPA), India.

Founder Director – Patient Advocacy,

Cure SMA Foundation of India, Hyderabad, India.

Co-Founder & Director

Rare Diseases India Foundation (RDIF), India.

Lead – Medical & Precision Oncology

Apollo Hospitals Navi Mumbai

Regional Coordinator

Organization for Rare Diseases India (ORDI), India.

Professor – Pediatrics

All India Institute of Medical Sciences (AIIMS), Bhopal, India.

Associate Consultant – Institute of Medical Genetics & Genomics

Sir Ganga Ram Hospital, New Delhi, India.

Former Business Unit Head – Rare Diseases

Takeda

Partners 2026

Watch Live Event

Event Highlights

GET IN TOUCH

IHW Council

Level 3B, DLF Centre, Sansad Marg,

Connaught Place,New Delhi – 110001

Secretariat Queries

Sales & Marketing Queries

[email protected]
+91 99119 88755


CONNECT WITH US